Literature DB >> 28899758

Chronic global analysis of vascular permeability and cerebral blood flow after bone marrow stromal cell treatment of traumatic brain injury in the rat: A long-term MRI study.

Lian Li1, Michael Chopp2, Guangliang Ding3, Qingjiang Li4, Asim Mahmood5, Quan Jiang6.   

Abstract

Vascular permeability and hemodynamic alteration in response to the transplantation of human bone marrow stromal cells (hMSCs) after traumatic brain injury (TBI) were longitudinally investigated in non directly injured and normal-appearing cerebral tissue using magnetic resonance imaging (MRI). Male Wistar rats (300-350g, n=30) subjected to controlled cortical impact TBI were intravenously injected with 1ml of saline (at 6-h or 1-week post-injury, n=5/group) or with hMSCs in suspension (∼3×106 hMSCs, at 6-h or 1-week post-injury, n=10/group). MRI measurements of T2-weighted imaging, cerebral blood flow (CBF) and blood-to-brain transfer constant (Ki) of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA), and neurological behavioral estimates were performed on all animals at multiple time points up to 3-months post-injury. Our long-term imaging data show that blood-brain barrier (BBB) breakdown and hemodynamic disruption after TBI, as revealed by Ki and CBF, respectively, affect both hemispheres of the brain in a diffuse manner. Our data reveal a sensitive vascular permeability and hemodynamic reaction in response to the time-dependent transplantation of hMSCs. A more rapid reduction of Ki following cell treatment is associated with a higher level of CBF in the injured brain, and acute (6h) cell administration leads to enhanced therapeutic effects on both the recovery of vascular integrity and stabilization of cerebral perfusion compared to delayed (1w) cell engraftment. Our results indicate that cell-enhanced BBB reconstitution plays an important role in underlying the restoration of CBF in the injured brain, which in turn, contributes to the improvement of functional outcome.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone marrow stromal cells; Cerebral blood flow; Intervention; MRI; Traumatic brain injury; Vascular permeability

Mesh:

Year:  2017        PMID: 28899758      PMCID: PMC5645040          DOI: 10.1016/j.brainres.2017.09.007

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  74 in total

1.  A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging.

Authors:  E C Wong; R B Buxton; L R Frank
Journal:  Magn Reson Med       Date:  1998-09       Impact factor: 4.668

Review 2.  Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury.

Authors:  Dan Shlosberg; Mony Benifla; Daniela Kaufer; Alon Friedman
Journal:  Nat Rev Neurol       Date:  2010-06-15       Impact factor: 42.937

3.  Changes of cerebral blood flow during the secondary expansion of a cortical contusion assessed by 14C-iodoantipyrine autoradiography in mice using a non-invasive protocol.

Authors:  Doortje C Engel; Günter Mies; Nicole A Terpolilli; Raimund Trabold; Alexander Loch; Chris I De Zeeuw; John T Weber; Andrew I R Maas; Nikolaus Plesnila
Journal:  J Neurotrauma       Date:  2008-07       Impact factor: 5.269

4.  An analysis of regional microvascular loss and recovery following two grades of fluid percussion trauma: a role for hypoxia-inducible factors in traumatic brain injury.

Authors:  Eugene Park; Joshua D Bell; Ishita P Siddiq; Andrew J Baker
Journal:  J Cereb Blood Flow Metab       Date:  2008-12-17       Impact factor: 6.200

5.  Distribution of brain oedema in the contralateral hemisphere after cerebral infarction: repeated MRI measurement in the rat.

Authors:  Y Izumi; M Haida; T Hata; K Isozumi; D Kurita; Y Shinohara
Journal:  J Clin Neurosci       Date:  2002-05       Impact factor: 1.961

6.  Mesenchymal stem cells stabilize the blood-brain barrier through regulation of astrocytes.

Authors:  Hyun Jung Park; Jin Young Shin; Ha Na Kim; Se Hee Oh; Sook K Song; Phil Hyu Lee
Journal:  Stem Cell Res Ther       Date:  2015-09-29       Impact factor: 6.832

7.  Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients.

Authors:  Akihiko Taguchi; Chiaki Sakai; Toshihiro Soma; Yukiko Kasahara; David M Stern; Katsufumi Kajimoto; Masafumi Ihara; Takashi Daimon; Kenichi Yamahara; Kaori Doi; Nobuo Kohara; Hiroyuki Nishimura; Tomohiro Matsuyama; Hiroaki Naritomi; Nobuyuki Sakai; Kazuyuki Nagatsuka
Journal:  Stem Cells Dev       Date:  2015-08-17       Impact factor: 3.272

8.  The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6.

Authors:  Min Chen; Xifeng Li; Xin Zhang; Xuying He; Lingfeng Lai; Yanchao Liu; Guohui Zhu; Wei Li; Hui Li; Qinrui Fang; Zequn Wang; Chuanzhi Duan
Journal:  J Neuroinflammation       Date:  2015-04-01       Impact factor: 8.322

9.  Early Cerebral Circulation Disturbance in Patients Suffering from Severe Traumatic Brain Injury (TBI): A Xenon CT and Perfusion CT Study.

Authors:  Mitsuru Honda; Ryo Ichibayashi; Hiroki Yokomuro; Katsunori Yoshihara; Hiroyuki Masuda; Daisuke Haga; Yoshikatsu Seiki; Chiaki Kudoh; Taichi Kishi
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-06-29       Impact factor: 1.742

10.  Activation of Alpha 7 Cholinergic Nicotinic Receptors Reduce Blood-Brain Barrier Permeability following Experimental Traumatic Brain Injury.

Authors:  Pramod K Dash; Jing Zhao; Nobuhide Kobori; John B Redell; Michael J Hylin; Kimberly N Hood; Anthony N Moore
Journal:  J Neurosci       Date:  2016-03-02       Impact factor: 6.167

View more
  1 in total

1.  Diffuse white matter response in trauma-injured brain to bone marrow stromal cell treatment detected by diffusional kurtosis imaging.

Authors:  Lian Li; Michael Chopp; Guangliang Ding; Esmaeil Davoodi-Bojd; Qingjiang Li; Asim Mahmood; Ye Xiong; Quan Jiang
Journal:  Brain Res       Date:  2019-04-19       Impact factor: 3.252

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.